A detailed syntheses of some fluorophenylaryl / heteroaryl ether derivatives 1a, b-4a, b have been described which was accomplished by using a variety of convenient phenolic coupling methods and subsequent Pd-C catalyzed hydrogenation of the coupled intermediates. The compounds synthesized are structurally similar to a number of anti-inflammatory agents.
Introduction
Earlier we published a research article where we described briefly the existence of intramolecular C-F---H-N hydrogen bonding using compounds 1-4, which were designed as covalently-linked base pair models of F (difluorotoluene deoxynucleoside) and A (adenine deoxynucleoside) ( Figure 1 ). 1, 2 Although our study failed to find any C-F---H-N intramolecular hydrogen bonding and supported Kool's theory that shape complementarities between the base pairs play the major role in DNA replication fidelity, 3 several papers have been published
subsequently showing intramolecular C-F--H-N interactions and the role of organic fluorine in hydrogen bonding by means of density functional theory, ab initio and MMFF force field calculations. 4 We couldn't explain definitely the reason of not finding intramolecular C-F---H-N hydrogen bonding and it was assumed that the problem might be the design of the compounds. Therefore we didn't proceed for further investigation. Later on we found that our compounds are structurally similar to a number of biologically interesting fluorophenylaryl ether type compounds ( Figure 2 ). 5, 6, 7 The most promising compounds belonging this class is Flosulide (I) and its sulfone analogue (II), which have already been proven as selective cyclo-oxygenase-2 The synthesis of compounds 1-4 was accomplished by using a variety of phenol coupling methods as key steps (Scheme 1 and 2). 4-Fluoro-1,2-phenylenediamine 5 11 was first converted into 5-fluorobenzimidazole 6 by heating in formic acid solution. Nitration of 6 under relatively mild conditions gave a mixture of two regioisomers 5-fluoro-4-nitrobenzimidazole 7 and 5-fluoro-6-nitrobenzimidazole 8. The 4-nitro compound 7 was subjected to KF-Al 2 O 3 12 mediated coupling with o-fluorophenol and p-fluorophenol in the presence of catalytic amount of 18-crown-6-ether 13 in MeCN to give fluorophenyl benzimidazole (heteroaryl) ethers 9a-9b. Pd-C catalyzed hydrogenation of 9a-9b at atmospheric pressure afforded compounds 1a-1b, respectively in excellent yields.
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In summary, we have demonstrated the detailed syntheses of some novel fluorophenylaryl / heteroaryl ether derivatives which are structurally similar to some potent anti-inflammatory agents like Flosulide. The synthetic procedures are more straightforward and convenient than the traditional multi-step syntheses. These synthetic studies are expected to be helpful to generate some highly potent compounds of similar biological activities. The biological activity studies of the synthesized compounds are in progress.
Experimental Section
General Procedures. All melting points were determined with a Yanagimoto Micro Melting Point apparatus and are uncorrected. IR spectra (cm -1 ) were recorded on a Perkin-Elmer 1600 
5-Fluorobenzimidazole (6).
A solution of 4-fluoro-1, 2-phenylenediamine 5 (3.5 g, 27.7 mmol) in 90% formic acid (50 ml) was heated at reflux for 2 h. 
5-Fluoro-4-nitrobenzimidazole (7) and 5-Fluoro-6-nitrobenzimidazole (8).
To a solution of 6 (5.5 g, 40.4 mmol) in concentrated sulphuric acid (6.4 ml, 120 mmol) was added concentrated nitric acid (5.1 ml, 120 mmol) slowly and the whole mixture was stirred at room temperature for 3h. The solution was poured into ice-water. A solid was formed which was filtered and subsequently washed with water and saturated sodium bicarbonate solution. The liquid portion was neutralized by adding KOH pellets. The solid still present was filtered off and the mother liquid was extracted with ethyl acetate (100 ml x 2). The total solids were taken and the organic portion was concentrated in vacuo. The residue was chromatographed on silica gel (3-5% methanol in dichloromethane) to give 7 (2.2 g, 30%) and 8 (4.07 g, 56%), both as a yellowish solid. 
5-(2-Fluorophenyl)-4-aminobenzimidazole ether (1a).
To a solution of 9a (107 mg, 0.391 mmol) in MeOH (10 ml) under N 2 was added Pd/C (20 mg) and H 2 gas was allowed to pass through the solution with stirring for 4 h until completion of the reaction by TLC. The reaction mixture was filtered off through a plug of celite and the filtrate was concentrated in vacuo. The residue was purified by silica gel column chromatography (chloroform-methanol 9:1) to yield 1a (91 mg, 96%) as a grey crystalline solid; mp 127-128 °C (from dichloromethane); Anal. 
5-(2-Fluorophenyl)-6-nitrobenzimidazole ether (10a).
To a stirred solution of 8 (200 mg, 1.10 mmol) in DMSO (5 ml) were added o-fluorophenol (0.147 ml, 1.10 mmol) and anhydrous K 2 CO 3 (334 mg, 2.20 mmol) and the mixture was heated at 100 °C for one week. The reaction mixture was diluted with ethyl acetate (100 ml) and was washed successively with 1M KOH (10 ml), water (20 ml), and brine (20 ml). The organic layer dried over anhydrous Na 2 SO 4 , concentrated in vacuo and the residue was purified by column chromatography over silica gel (chloroform-methanol 9:1) to yield the product 10a ( 
5-(2-Fluorophenyl)-6-aminobenzimidazole ether (2a).
To the solution of 10a (20.0 mg, 0.073 mmol) in dry methanol (10 ml) was added Pd/C (10 mg) and H 2 gas was allowed to pass for 4 h. The reaction mixture was filtered through a plug of celite and the filtrate was concentrated in vacuo to give the residue which was purified by preparative TLC (chloroform-methanol 9:1) to yield 2a (13.0 (1.40 g, 8.92 mmol) in one portion and heated at 120 °C for 2 h. The reaction mixture was diluted with ethyl acetate (100 ml) and brine (20 ml) was added to it. The whole mixture was successively washed with 1 M NaOH (20 ml), 1 M HCl (20 ml) and brine (20 ml). The organic portion was dried over anhydrous Na 2 SO 4 and concentrated in vacuo. 
2-(2-Fluorophenyl) phenylamine ether (3a)
. To a solution of 12a (200 mg, 0.858 mmol) in anhydrous methanol (10 ml) under nitrogen was added Pd/C (50.0 mg). The flask was evacuated and hydrogen gas was allowed to pass through the solution overnight. After being ensured of the completion of the reaction by TLC, the reaction mixture was filtered through a plug of celite to remove Pd/C and the filtrate was concentrated and purified by column chromatography on silica gel (hexane-ethyl acetate 9:1) to give 3a 203.0746.
3-(2-Fluorophenyl)-2-nitropyridyl ether (14a).
To a stirred dispersion of o-fluorophenol (0.32 ml, 3.52 mmol) and NaH (140 mg, 5.83 mmol) in THF (5 ml) was added 3-fluoro-2-nitropyridine 13 (100 mg, 0.703 mmol) and stirred for 2 h. The reaction was quenched by saturated aqueous NH 4 Cl (30 ml) solution and extracted with ethyl acetate (250 ml). The organic layer was washed with brine (100 ml), dried over Na 2 SO 4 , filtered and concentrated in vacuo. The crude residue was purified by column chromatography over silica gel (hexanedichloromethane 6:4) to give 14a (101 mg, 61%) as a yellow oil; IR (neat, cm 
3-(4-Fluorophenyl)-2-nitropyridyl ether (14b).
Compound 14b (128 mg, 39%) was prepared by following the procedure analogous to 14a using 13 (200 mg, 1.41 mmol), p-fluorophenol (789 mg, 7.04 mmol) and NaH (282 mg, 7.04 mmol) as a yellowish solid; mp 61-62 °C (from hexane-
